Search Results
Viewing: 461-470 of 544 | All
Article
Level 4 Epilepsy Program
The National Association of Epilepsy Centers has accredited the Epilepsy Center at Nationwide Children’s as a Level 4 epilepsy program, a designation reserved for programs offering the highest level of comprehensive and specialized care.
Article
Referrals and Scheduling
We accept patient referrals and appointment requests through several options. Choose the option that works best for you.
Article
Sign Up for PediatricsOnline
Subscribe to PediatricsOnline, a digital newsletter personalized for the pediatric provider to deliver up-to-date resources, research announcements and more.
Condition
Agenesis of the Corpus Callosum
Agenesis of the corpus callosum (ACC) is a rare, congenital brain defect where a structure called the corpus callosum does not develop normally. The corpus callosum is a band of tissue connecting the left and right sides of the brain. The severity of the symptoms due to ACC is highly variable.
Article
Martin Lab
Under the direction of Paul Martin, PhD, the Martin Lab's goal is to develop curative therapies for children with neuromuscular and lysosomal disorders, including forms of muscular dystrophy, lysosomal storage disorders, myopathies and motor neuron diseases.
Article
Martin Lab Staff
Learn more about principal investigator Paul Martin, PhD, and his dynamic team in the Martin Lab.
News
MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy
More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grassroots special events, has culminated in MDA providing financial assistance for the start of the first phase 2
Article
Rashnonejad Lab
Under the direction of Afrooz Rashnonejad, MSc, PhD, the Rashnonejad Lab focuses on developing adeno-associated virus (AAV)-based gene therapies for neuromuscular and neurodegenerative diseases.
News
Nationwide Children's Hospital Study Named Among Top Ten Clinical Research Achievement Awards by the Clinical Research Forum
The first clinical trial to test the functional replacement of the mutated gene responsible for SMA1 will be recognized at the 2018 Top Ten Clinical Research Achievement Awards at the National Press Club in Washington, D.C., on April 18, 2018.
News
No More Sitting in the Dark?
A new study by researchers at the Center for Injury Research and Policy, Sports Medicine, and Emergency Medicine at Nationwide Children’s Hospital investigated objectively measured, self-paced physical and cognitive activity across the first week post-concussion.